These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25210008)

  • 1. The middle child in heart failure: heart failure with mid-range ejection fraction (40-50%).
    Lam CS; Solomon SD
    Eur J Heart Fail; 2014 Oct; 16(10):1049-55. PubMed ID: 25210008
    [No Abstract]   [Full Text] [Related]  

  • 2. Sex-related similarities and differences in responses to heart failure therapies.
    Chyou JY; Qin H; Butler J; Voors AA; Lam CSP
    Nat Rev Cardiol; 2024 Jul; 21(7):498-516. PubMed ID: 38459252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Asian" Heart Failure.
    Yoo SGK; Lam CSP; Sweitzer NK
    Circulation; 2024 Jul; 150(3):177-179. PubMed ID: 39008555
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study.
    Tsuji K; Sakata Y; Nochioka K; Miura M; Yamauchi T; Onose T; Abe R; Oikawa T; Kasahara S; Sato M; Shiroto T; Takahashi J; Miyata S; Shimokawa H;
    Eur J Heart Fail; 2017 Oct; 19(10):1258-1269. PubMed ID: 28370829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fussing Over the Middle Child: Heart Failure With Mid-Range Ejection Fraction.
    Lam CS; Solomon SD
    Circulation; 2017 Apr; 135(14):1279-1280. PubMed ID: 28373521
    [No Abstract]   [Full Text] [Related]  

  • 6. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions.
    Hsu JJ; Ziaeian B; Fonarow GC
    JACC Heart Fail; 2017 Nov; 5(11):763-771. PubMed ID: 29032140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).
    Rickenbacher P; Kaufmann BA; Maeder MT; Bernheim A; Goetschalckx K; Pfister O; Pfisterer M; Brunner-La Rocca HP;
    Eur J Heart Fail; 2017 Dec; 19(12):1586-1596. PubMed ID: 28295985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure with mid-range ejection fraction in patients admitted to internal medicine departments: Findings from the RICA Registry.
    Guisado-Espartero ME; Salamanca-Bautista P; Aramburu-Bodas Ó; Conde-Martel A; Arias-Jiménez JL; Llàcer-Iborra P; Dávila-Ramos MF; Cabanes-Hernández Y; Manzano L; Montero-Pérez-Barquero M;
    Int J Cardiol; 2018 Mar; 255():124-128. PubMed ID: 29305104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What have we learned about heart failure with mid-range ejection fraction one year after its introduction?
    Nauta JF; Hummel YM; van Melle JP; van der Meer P; Lam CSP; Ponikowski P; Voors AA
    Eur J Heart Fail; 2017 Dec; 19(12):1569-1573. PubMed ID: 29067761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors and outcomes of heart failure with mid-range ejection fraction.
    Bhambhani V; Kizer JR; Lima JAC; van der Harst P; Bahrami H; Nayor M; de Filippi CR; Enserro D; Blaha MJ; Cushman M; Wang TJ; Gansevoort RT; Fox CS; Gaggin HK; Kop WJ; Liu K; Vasan RS; Psaty BM; Lee DS; Brouwers FP; Hillege HL; Bartz TM; Benjamin EJ; Chan C; Allison M; Gardin JM; Januzzi JL; Levy D; Herrington DM; van Gilst WH; Bertoni AG; Larson MG; de Boer RA; Gottdiener JS; Shah SJ; Ho JE
    Eur J Heart Fail; 2018 Apr; 20(4):651-659. PubMed ID: 29226491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction.
    Löfman I; Szummer K; Dahlström U; Jernberg T; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1606-1614. PubMed ID: 28371075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mid-range left ventricular ejection fraction: Clinical profile and cause of death in ambulatory patients with chronic heart failure.
    Pascual-Figal DA; Ferrero-Gregori A; Gomez-Otero I; Vazquez R; Delgado-Jimenez J; Alvarez-Garcia J; Gimeno-Blanes JR; Worner-Diz F; Bardají A; Alonso-Pulpon L; Gonzalez-Juanatey JR; Cinca J;
    Int J Cardiol; 2017 Aug; 240():265-270. PubMed ID: 28318662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
    Chioncel O; Lainscak M; Seferovic PM; Anker SD; Crespo-Leiro MG; Harjola VP; Parissis J; Laroche C; Piepoli MF; Fonseca C; Mebazaa A; Lund L; Ambrosio GA; Coats AJ; Ferrari R; Ruschitzka F; Maggioni AP; Filippatos G
    Eur J Heart Fail; 2017 Dec; 19(12):1574-1585. PubMed ID: 28386917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precipitating Clinical Factors, Heart Failure Characterization, and Outcomes in Patients Hospitalized With Heart Failure With Reduced, Borderline, and Preserved Ejection Fraction.
    Kapoor JR; Kapoor R; Ju C; Heidenreich PA; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
    JACC Heart Fail; 2016 Jun; 4(6):464-72. PubMed ID: 27256749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study.
    Vedin O; Lam CSP; Koh AS; Benson L; Teng THK; Tay WT; Braun OÖ; Savarese G; Dahlström U; Lund LH
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28615366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials.
    Cleland JGF; Bunting KV; Flather MD; Altman DG; Holmes J; Coats AJS; Manzano L; McMurray JJV; Ruschitzka F; van Veldhuisen DJ; von Lueder TG; Böhm M; Andersson B; Kjekshus J; Packer M; Rigby AS; Rosano G; Wedel H; Hjalmarson Å; Wikstrand J; Kotecha D;
    Eur Heart J; 2018 Jan; 39(1):26-35. PubMed ID: 29040525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure with mid-range ejection fraction: a transition phenotype?
    Bayés-Genís A; Núñez J; Lupón J
    Eur J Heart Fail; 2017 Dec; 19(12):1635-1637. PubMed ID: 28948680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.